The MarketWatch News Department was not involved in the creation of this content. Program ensures continued access to treatment for patients enrolled in the Federal Employee & Retirees Health Plan ...

The MarketWatch News Department was not involved in the creation of this content. Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

DelveInsight's“ Open-angle Glaucoma Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Open-angle Glaucoma pipeline landscape. It covers ...

Endoscopic cyclophotocoagulation combined with cataract surgery was better at lowering IOP than cataract surgery alone in ...

Their 'One That Got Away' Married Someone Else. This Was The Hardest Thing To Accept. What Amazon’s mass layoffs are really about Huge Brazilian raid on Rio gang leaves at least 60 people dead and 81 ...

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and ...

JAMES CITY COUNTY, Va. — Drivers traveling on I-64 east should expect an overnight closure this week as crews install a new overhead sign, according to the Virginia Department of Transportation (VDOT) ...

Data to be shared during an ObesityWeek press conference includes four of seven data presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Oct. 28, 2025 ...

Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical company that delivers life-changing medicines to patients with chronic, progressive diseases, today announced that leading obesity experts will ...